logo

For the Inventor, By the Inventor

San Diego, CA, United States of America

Bryan Becklund

This inventor holds 4 USPTO granted patents and 6 published patent applications. Top assignees: Inhibrx Biosciences, Inc., Phylaxis Bioscience, LLC. Active years: 2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Bryan Becklund. Retrieved from https://idiyas.com/inventor/bryan-becklund-tzdcxoxs

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 4 

% Patents Active = 100.0

Average Co-Inventor Count = 7.6

ph-index = 1


Company Filing History:

goldMedal4 out of 11 
 
Inhibrx Biosciences, Inc.
 patents
silverMedal1 out of 1 
 
Phylaxis Bioscience, LLC
 patent
where one patent can have more than one assignee

Years Active: 2025

Loading Chart...
4 patents (USPTO):Explore Patents
1. 12331126 - OX40-binding polypeptides and uses thereof (2025-06-17),
2. 12234297 - IgE binding proteins and uses thereof (2025-02-25),
3. 12227584 - Multivalent and multispecific OX40-binding fusion proteins (2025-02-18),
4. 12187804 - Multivalent and multispecific 41BB-binding proteins (2025-01-07),

Title: The Innovative Contributions of Bryan Becklund

Introduction

Bryan Becklund is a notable inventor based in San Diego, California. He has made significant contributions to the field of biotechnology, particularly in the development of polypeptides that have therapeutic applications. With a total of four patents to his name, Becklund's work is paving the way for advancements in medical treatments.

Latest Patents

Among his latest patents is the invention of OX40-binding polypeptides and their uses. This patent provides VHH-containing polypeptides that bind to OX40, with some embodiments focusing on those that agonize OX40. Additionally, he has developed IgE-binding proteins and their uses, which include VHH domains, polypeptides, and proteins that modulate the biological activity of IgE.

Career Highlights

Bryan Becklund has worked with several prominent companies in the biotechnology sector. Notably, he has been associated with Inhibrx Biosciences, Inc. and Phylaxis Bioscience, LLC. His work in these organizations has contributed to the advancement of innovative therapies and treatments.

Collaborations

Becklund has collaborated with several professionals in his field, including Brendan P Eckelman and Kyle S Jones. These collaborations have further enhanced his research and development efforts.

Conclusion

Bryan Becklund's innovative work in biotechnology, particularly through his patents, showcases his commitment to advancing medical science. His contributions are significant in the ongoing quest for effective treatments and therapies.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…